科研级 Spesolimab, Anti-IL36RN Recombinant Antibody, Research Grade Spesolimab
Molecular Name
Spesolimab
Size
1mg, 5mg
CAS Number
2097104-58-8
Isotype
IgG1 Kappa
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
IL36RN[Homo sapiens]
Background
Sintilimab, sold under the brand Tyvyt among others, is a medication used to treat Hodgkin's disease, and has been approved in China. It is a fully human IgG4 monoclonal antibody that binds to programmed cell death protein 1.